Company Long-Term Loans and Borrowings: Fractyl (GUTS)

Public company logo of Fractyl (GUTS)

Fractyl Health, Inc. (GUTS) restores natural metabolism by eliminating the root causes of diabetes through tissue regeneration. This US developer leverages advanced obesity treatment methods and support from specialized investors. Current price action on GURU.Markets is 0.00, while the business focuses on identifying strategic partners for the subsequent licensing of its platform following the completion of clinical trials.

GUTS Fractyl Health, Inc. Company Long-Term Debts (02/21/2024 - 10/29/2026)

Summary analytical data breakdowns for Fractyl (GUTS)

- market price and analyst price targets:
Stock Price fractyl.com|GUTS - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Fractyl Health|GUTS - Total Company Value
- book capitalization information:
Accounting Value per Share Fractyl Health|GUTS - Book Capitalization|Market Capitalization to Book Value Ratio fractyl.com|GUTS - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Fractyl Health, Inc.|GUTS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Fractyl Health, Inc|GUTS - Company Aggregate Debts|Debts to Book Value Fractyl Health|GUTS - Company Long-Term Liabilities|Amount of Current Liabilities Fractyl Health|Quick Ratio fractyl.com
- earnings and multiples data:
GUTS - Net Profit
Summary company analytics:Fractyl Health, Inc.
Brand item of Fractyl Health, Inc.

The 0.00 metric is formed by aggregating all liabilities with a maturity of more than one year, reflecting the business's dependence on external financing. Amid competition from GLP-1 drugs and clinical trial risks, analyzing the long-term debt of Fractyl Health, Inc. (GUTS) allows for an assessment of the company's financial resilience to develop invasive diabetes treatments without critical pressure from creditors.

Competitor analysis for Fractyl Health, Inc.

Company Long-Term Debts ascendispharma.com ASND|MDGL - Company Long-Term Debt|Company Long-Term Loans and Borrowings CORT (Corcept Therapeutics Inc.)|Rhythm Pharmaceuticals Inc (RYTM) - Company Long-Term Debt|Company Long-Term Liabilities Akero Corp|MTSR (Metsera Inc) - Company Long-Term Debts|Company Long-Term Debts moonlaketx.com|Company Long-Term Liabilities CRNX (Crinetics)|NAMS (NewAmsterdam Pharma Company) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Soleno SLNO|FOLD - Company Long-Term Liabilities|89bio, Inc. - Company Long-Term Debts|Long-Term Debt agios.com|GPCR (Structure Therapeutics Inc.) - Company Long-Term Liabilities|MDXG: Amount of Long-Term Liabilities|RZLT (Rezolute Corp) - Company Long-Term Debts|Company Long-Term Debts Lexicon Corp|Company Long-Term Debts MBX|Company Long-Term Debt ALT (altimmune.com)|Company Long-Term Debt Aardvark Therapeutics AARD|Sagimet Biosciences, Inc. (SGMT) - Long-Term Debt|BIOA - Company Long-Term Debt|BMEA: Company Long-Term Debt|QNCX: Company Long-Term Debts|VTVT - Long-Term Debt Volume|Company Long-Term Debt Agape ATP Corp|Pluri Inc (PLUR) - Long-Term Debt Volume|Company Long-Term Debt Synlogic, Inc. (SYBX)|Company Long-Term Liabilities Lipocine Corporation LPCN|Company Long-Term Debts MTNB (Matinas BioPharma Holdings)|SPRB (Spruce Biosciences Inc.) - Long-Term Liabilities|GLTO - Company Long-Term Debt|Company Long-Term Loans and Borrowings CTCX (Carmell Corp.)|LUMO: Company Long-Term Debts|Organovo Corp (ONVO) - Company Long-Term Debts|RDUS (Radius Recycling, Inc.) - Company Long-Term Debts